as part of Safer Opioid Supply Programs Evaluation in Toronto, Ontario

In this study, we examined barriers and facilitators that influenced the implementation of integrated safer supply pilot programs (ISSPP) across Canada.

as part of Safer Opioid Supply Programs Evaluation in Toronto, Ontario

We conducted a systematic review of qualitative studies on safer opioid supply client experiences published between January 2016 and August 2024.

as part of Piloting and Evaluating Drug Checking Services in Toronto, Ontario

This article outlines the need for evidence-based reforms in Toronto’s drug supply approach in the context of fluctuations in potency and increasing lethality of the city’s unregulated opioid market, particularly regarding carfentanil.

as part of Policy Impact Unit

This report aims to inform Ontario’s cannabis retail sector by offering actionable steps to strengthen inclusion and diversity in Ontario’s cannabis industry based on available evidence and best practices in other jurisdictions with legal cannabis markets.

as part of T-DOT (Toronto Disparities, Overdose and Treatment)

Supervised consumption services (SCS) are effective at preventing overdose mortality. However, their effect on public safety remains contested. We investigated homicide rates in areas near SCS in Toronto.

The United States is grappling with a worsening overdose crisis fueled by synthetic opioids like fentanyl, with overdose deaths reaching unprecedented levels. While some propose tariffs on neighboring countries as a solution, such measures risk undermining regional cooperation without effectively addressing the adaptable networks behind drug trafficking. Instead, a comprehensive, evidence-based public health strategy is essential to tackle the crisis and its underlying drivers.

as part of Safer Opioid Supply Programs Evaluation in Toronto, Ontario

Safer opioid supply programs in Canada have come under intense scrutiny related to the perceived risk of diversion of safer opioid supply medications. We sought to explore the experiences and perspectives of safer opioid supply medication diversion with clients of a safer opioid supply program in Toronto, Canada.

On August 20th, 2024, the Ontario provincial government announced new legislation that would force the closure of most of Ontario’s supervised consumption services. This ban was announced without presenting any supporting scientific, clinical, or public health evidence. This report, is intended to fill this gap. Read about the range of public health and safety impacts these sites provide for our community.

In this study, researchers examined people who inject drugs in Kyrgyzstan and compared those using "salts" with those who did not. They found that salt users engaged in riskier injection behaviours, were less likely to use syringe service programs, and may face higher risk for HIV and other blood-borne viruses.

as part of Systematic Reviews on Drug Policy

This systematic review assesses how sex and gender are considered in alcohol treatment research for youth, finding that most studies conflate these factors and rarely include trans or intersex participants, highlighting the need for more inclusive and precise research practices.